Seno, Exille .

HRN: 27-02-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/19/2026
04/19/2026
IV
500 Mg
Q8 X 2 Doses
SP CS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: